Status in Israel
Presentation and Status in Health Basket
| Presentation | Basket | Yarpa | Pharmasoft |
|---|---|---|---|
|
Film Coated Tablets 30 |
|
Related information
Dosage
The recommended dosage is one 250 mg tablet once a day, with or without food.
Indications
Treatment of adult patients with locally advanced or metastatic Non‐small cell lung cancer (NSCLC) with activating mutations of EGFR‐TK.
Contra-Indications
Hypersensitivity to the active substance or any of its excipients.
Lactation.
Manufacturer
Teva Pharmaceutical Industries Ltd, Israel
Licence holder
